News About: Pharm. Industry
Lucentis improves vision in patients with wet age-related macular degeneration
Korean scientists announced positive six-month data of Novatis's Lucentis (ranibizumab) from a local clinical study.
The study successfully reached its primary endpoints and reported unprecedented results in mainta...
Drug makers moving to seek alliance
Rebate-troubled domestic and foreign pharmaceutical firms are moving to form their alliance, industry business sources said.
The Korea Pharmaceutical Manufacturers Association Vice Chairman Moon Kyung-tae will have...
Small- and medium-sized drug makers call for delay planned GMP regulations
The Korea Pharmaceutical Industry Cooperation (KPIC), a lobby group of 200 small- and medium-sized pharmaceutical firms, said on November 7 that the government's proposed global standard GMP (cGMP) be postponed until ...
Choong-wae Medical signs big medical device dealLocal medical device maker Choon-wae Medical Corporation, an affiliated company of Choong-wae Holding, has signed a contract with a German company to export its state-of-the-art...
|
KPTA to support scientific congress via lawful procedures
The Korea Pharmaceutical Manufacturers Association plans to support scientific events to be hosted by two doctor groups including the Korea Academy of Medical Sciences via deposit designation system.
A KPMA officia...
Ilyang files ilaprazoleIlyang Pharm has submitted a marketing application of ilaprazole, its new investigational proton pump inhibitor (PPI), to the Korea Food and Drug Administration.
This is the ...
|
Yungjin's Q10 Life goes on saleYungjin Pharm has launched its Q10 Life capsule containing Coenzyme Q10 100 mg, vitamin E etc.
Last September, Yungjin joined hands with Japanese chemical and resin maker Kan...
|
3M launches new fluoride vanish3M has launched Fluoride Varnish CavityShield (5% NaF), a topical fluoride, which are recommended as a preventive strategy for dental health care of children and adolescents.
...
|
Excessive use of drugs blamed for price hike: forum
The prevailing trend of using excessive number of drugs per patient should be blamed for soaring insurance coverage for medicines, Han Oh-seok, director of Korea Institute for Pharmaceutical Policy Affairs (KIPPA) sai...
Hanmi to achieve W500 bil. in sales this year
Hanmi Pharm aims to achieve 500 billion won in this year's sales this year with the intention of emerging as one of the global companies in the world, a company official said.
We could reach a 500-billion won level...
